Navigation Links
FDA Imposes New Restrictions On Roche's Accutane

Women taking Roche Inc's popular acne treatment Accutane (isotretinoin) will soon have to submit to new restrictions aimed at preventing unwanted pregnancies while on the drug. The US Food and Drug Administration (FDA) said that it has approved significant changes to the drugmaker's pregnancy prevention programme. The pregnancy prevention programme was adopted about 13 years ago, when Accutane was conclusively linked to birth defects and even faetal death.//

But in recent years, case reports have demonstrated that some women on the drug continued to get pregnant despite these well-document side effects. The FDA said that the new restrictions will include requiring women to take a pregnancy test every month to prove that they are not pregnant as well as to sign a consent form, showing that they are aware of the potential risks. The FDA added that pharmacists would now be restricted to dispensing a one-month supply to ensure that these restrictions are followed. The typical treatment period is about six months.

In order to make the programme work, the FDA said that physicians wishing to prescribe the drug would receive yellow "Accutane Qualification Stickers'' that must be placed on the prescription as a means of verifying the negative pregnancy test and that the patient received the appropriate counseling. ''This sticker will indicate to the pharmacists that the patient is 'qualified,' the FDA said in a statement.
'"/>




Page: 1

Related medicine news :

1. Bird Flu Restrictions To Be Lifted In Scotland
2. Restrictions Imposed on Sale of Edible Common Salt
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... to and which He does not. Yisrayl says with so many titles and names ... name, but he says with a little Scripture, backed with a lot of research, the ...
(Date:4/28/2017)... ... 28, 2017 , ... Intellitec Solutions announced the publication of ... Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. With ... care, Brooke Grove now has the capability to achieve its goal for a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
Breaking Medicine Technology: